Clinical Practice

Use the tool below to view all available Global Women's Health Academy Series

Exploring the Impact of Insomnia on Daytime Functioning and Cognition
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
MinuteCE®
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
0.75 program credits
- Michael E. Yurcheshen, MD, FAASM
  Peer
- Kevin Trice, MD
  Peer
0.75 program credits
Sleep Architecture and Neurotransmitters of Sleep
Sleep Architecture and Neurotransmitters of Sleep
MinuteCE®
Sleep Architecture and Neurotransmitters of Sleep
0.75 program credits
- Michael E. Yurcheshen, MD, FAASM
  Peer
0.75 program credits
Examining Treatment Options for Insomnia: From Orexin to GABA
Examining Treatment Options for Insomnia: From Orexin to GABA
MinuteCE®
Examining Treatment Options for Insomnia: From Orexin to GABA
0.75 program credits
- Kevin Trice, MD
  Peer
0.75 program credits
MinuteCE®
Insomnia Treatment Goals: Restful Nights and Productive Days
0.75 credits 6 episodes
- Kevin Trice, MD
  Peer
- Michael E. Yurcheshen, MD, FAASM
  Peer
0.75 credits 6 episodes
The Role of PARP Inhibitors in Metastatic Breast Cancer
The Role of PARP Inhibitors in Metastatic Breast Cancer
Project Oncology®
The Role of PARP Inhibitors in Metastatic Breast Cancer
Experts Debate: How Novel Excessive Daytime Sleepiness Treatments Fit Into Clinical Practice for Obstructive Sleep Apnea
Experts Debate: How Novel Excessive Daytime Sleepiness Treatments Fit Into Clinical Practice for Obstructive Sleep Apnea
MinuteCE®
Experts Debate: How Novel Excessive Daytime Sleepiness Treatments Fit Into Clinical Practice for Obstructive Sleep Apnea
1.00 program credit
- Atul Malhotra, MD
  Peer
- Neomi Shah, MD, MPH, MSc
  Peer
1.00 program credit
Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea
MinuteCE®
Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea
1.00 program credit
- Neomi Shah, MD, MPH, MSc
  Peer
1.00 program credit
New Treatments for Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
New Treatments for Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
MinuteCE®
New Treatments for Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
1.00 program credit
- Christina Finch, MD
  Peer
1.00 program credit
Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
MinuteCE®
Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
1.00 program credit
- Atul Malhotra, MD
  Peer
- Neomi Shah, MD, MPH, MSc
  Peer
1.00 program credit
Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups
Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups
MinuteCE®
Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups
1.00 program credit
- Christina Finch, MD
  Peer
1.00 program credit
Optimizing Vulvovaginitis Care: A Look at Screening Modalities & Treatment Guidelines
Optimizing Vulvovaginitis Care: A Look at Screening Modalities & Treatment Guidelines
Clinician's Roundtable
Optimizing Vulvovaginitis Care: A Look at Screening Modalities & Treatment Guidelines
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Oluwatosin Goje, MD
  Peer
Reducing the Burden of Vulvovaginitis with Improved Diagnostics & Therapies
Reducing the Burden of Vulvovaginitis with Improved Diagnostics & Therapies
Clinician's Roundtable
Reducing the Burden of Vulvovaginitis with Improved Diagnostics & Therapies
- Oluwatosin Goje, MD
  Peer
Selecting Therapy for ER+/HER2- Metastatic Breast Cancer: Key Factors to Consider
Selecting Therapy for ER+/HER2- Metastatic Breast Cancer: Key Factors to Consider
Project Oncology®
Selecting Therapy for ER+/HER2- Metastatic Breast Cancer: Key Factors to Consider
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Megan Kruse, MD
  Peer
Treating Metastatic Breast Cancer After the First-Line Setting: What to Do Next?
Treating Metastatic Breast Cancer After the First-Line Setting: What to Do Next?
Project Oncology®
Treating Metastatic Breast Cancer After the First-Line Setting: What to Do Next?
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Hope S. Rugo, MD, FASCO
  Peer
Spotlight on SERDs for ER+/HER2- Advanced Breast Cancer: What Clinicians Need to Know
Spotlight on SERDs for ER+/HER2- Advanced Breast Cancer: What Clinicians Need to Know
Project Oncology®
Spotlight on SERDs for ER+/HER2- Advanced Breast Cancer: What Clinicians Need to Know
- Jennifer Caudle, DO
  Peer
- Nan Chen, MD
  Peer
The EMERALD Trial: Comparing an Oral SERD vs. Endocrine Therapy for Advanced Breast Cancer
The EMERALD Trial: Comparing an Oral SERD vs. Endocrine Therapy for Advanced Breast Cancer
Project Oncology®
The EMERALD Trial: Comparing an Oral SERD vs. Endocrine Therapy for Advanced Breast Cancer

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Popular

Title

Share on ReachMD

Get a Dose of Global Women's Health Academy in Your Inbox and Practice Smarter Medicine